3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Motor Activity
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Leukemia
1
Interventions
Exercise
55
Resistance Training
9
Nutritional Status
6
Control Groups
5
Surveys and Questionnaires
4
Standard of Care
4
Diet
4
Preoperative Exercise
3
Nutrition Assessment
3
Methods
3
High-Intensity Interval Training
3
Counseling
3
lime
2
Vitamin D
2
Physical Therapy Modalities
2
Palliative Care
2
Interviews as Topic
2
Exercise Therapy
2
Exercise Test
2
Dosage Forms
2
Diet Therapy
2
Blood Specimen Collection
2
pembrolizumab
1
diacetamate
1
cytisine
1
cemiplimab
1
beta-Glucans
1
avelumab
1
YES1 protein, human
1
Whey Proteins
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Motor Activity
×
Roflumilast
×
1 year
×
Clear all
NCT06643221
2026-06-05
Allo-X
University of Arizona
Phase EARLY_PHASE1
Recruiting
200 enrolled